These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8070290)

  • 1. [The extracellular matrix and liver disease: a study with enzymoimmunological assay].
    Gao F; Kong XT; Wang XL
    Zhonghua Nei Ke Za Zhi; 1994 Feb; 33(2):109-12. PubMed ID: 8070290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The clinic significance of serum hyaluronate and tumor necrosis factor alpha levels in liver diseases].
    Zou B; Ling Q; Huo J; Lin L; He J; Pan Y
    Hunan Yi Ke Da Xue Xue Bao; 1998; 23(1):97-9. PubMed ID: 10681811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum hyaluronic acid and laminin as biomarkers in liver fibrosis.
    Parsian H; Rahimipour A; Nouri M; Somi MH; Qujeq D; Fard MK; Agcheli K
    J Gastrointestin Liver Dis; 2010 Jun; 19(2):169-74. PubMed ID: 20593050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A quantitative study of the relationship between levels of liver fibrosis markers in sera and fibrosis stages of liver tissues of patients with chronic hepatic diseases].
    Ding XJ; Li SB; Li SZ; Liu HS; Liu B; Xu FM; Gu RW
    Zhonghua Gan Zang Bing Za Zhi; 2005 Dec; 13(12):911-4. PubMed ID: 16381637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Correlation between liver fibrosis stage and serum liver fibrosis markers in patients with chronic hepatitis B].
    Ding H; Chen Y; Feng X; Liu D; Wu A; Zhang L
    Zhonghua Gan Zang Bing Za Zhi; 2001 Apr; 9(2):78-80. PubMed ID: 11350682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of liver fibrosis development in chronic hepatitis B patients by serum hyaluronic acid and laminin levels.
    Parsian H; Rahimipour A; Nouri M; Somi MH; Qujeq D
    Acta Clin Croat; 2010 Sep; 49(3):257-65. PubMed ID: 21462814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased serum levels of hyaluronate in liver disease.
    Engström-Laurent A; Lööf L; Nyberg A; Schröder T
    Hepatology; 1985; 5(4):638-42. PubMed ID: 4018736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of serum fibrosis indexes in patients with chronic hepatitis and its significance.
    Zheng M; Cai W; Weng H; Liu R
    Chin Med J (Engl); 2003 Mar; 116(3):346-9. PubMed ID: 12781034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular weight of hyaluronate in the serum of patients with chronic liver disease.
    Murawaki Y; Ikuta Y; Idobe Y; Koda M; Kawasaki H
    Res Commun Mol Pathol Pharmacol; 1998 Feb; 99(2):207-16. PubMed ID: 9583094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum hyaluronate and type III procollagen aminoterminal propeptide concentration in chronic liver disease. Relationship to cirrhosis and disease activity.
    Ramadori G; Zöhrens G; Manns M; Rieder H; Dienes HP; Hess G; Meyer KH; Büschenfelde Z
    Eur J Clin Invest; 1991 Jun; 21(3):323-30. PubMed ID: 1909636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnostic value of five serum markers for liver fibrosis].
    Luo R; Yang S; Xie J; Zhao Z; He Y; Yao J
    Zhonghua Gan Zang Bing Za Zhi; 2001 Jun; 9(3):148-50. PubMed ID: 11412388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The predictive value of serum laminin for portal hypertension in chronic liver diseases.
    Gressner AM; Tittor W; Kropf J
    Hepatogastroenterology; 1988 Jun; 35(3):95-100. PubMed ID: 3402906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum hyaluronate in liver diseases: study by enzymoimmunological assay.
    Frébourg T; Delpech B; Bercoff E; Senant J; Bertrand P; Deugnier Y; Bourreille J
    Hepatology; 1986; 6(3):392-5. PubMed ID: 3710427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum surrogate markers of liver fibrosis in primary biliary cirrhosis.
    Voumvouraki A; Koulentaki M; Notas G; Sfakianaki O; Kouroumalis E
    Eur J Intern Med; 2011 Feb; 22(1):77-83. PubMed ID: 21238899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The diagnostic value of serum hyaluronic acid, 7S domain of type IV collagen and AST/ALT ratio as markers of hepatic fibrosis in chronic hepatitis B and cirrhosis patients].
    Park JH; Park CK; Kim ES; Park SY; Jo CM; Tak WY; Kweon YO; Kim SK; Choi YW
    Taehan Kan Hakhoe Chi; 2003 Jun; 9(2):79-88. PubMed ID: 12824747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Value of simultaneous determination of serum hyaluronic acid, collagen type IV and the laminin level in diagnosing liver fibrosis].
    Liang XH; Zheng H
    Hunan Yi Ke Da Xue Xue Bao; 2002 Feb; 27(1):67-8. PubMed ID: 12575242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of serum laminin P1, procollagen-III peptides, and N-acetyl-beta-glucosaminidase for monitoring the activity of liver fibrosis.
    Schneider M; Voss B; Högemann B; Eberhardt G; Gerlach U
    Hepatogastroenterology; 1989 Dec; 36(6):506-10. PubMed ID: 2693303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of serum hyaluronate concentrations in patients with alcoholic liver disease.
    Tsutsumi M; Urashima S; Takase S; Ueshima Y; Tsuchishima M; Shimanaka K; Kawahara H
    Alcohol Clin Exp Res; 1997 Dec; 21(9):1716-21. PubMed ID: 9438536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum hyaluronate reflects hepatic fibrogenesis in alcoholic liver disease and is useful as a marker of fibrosis.
    Parés A; Deulofeu R; Giménez A; Caballería L; Bruguera M; Caballería J; Ballesta AM; Rodés J
    Hepatology; 1996 Dec; 24(6):1399-403. PubMed ID: 8938169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Serum type IV collagen and laminin in patients with chronic hepatitis and its clinical significance].
    Xie J; OuYang K; Su T
    Hunan Yi Ke Da Xue Xue Bao; 1998; 23(1):93-6. PubMed ID: 10681810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.